Monjazeb, A. M., Daly, M. E., Luxardi, G., Maverakis, E., Merleev, A. A., Marusina, A. I., . . . Riess, J. W. (2023). Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: A multi-institutional phase I trial. Nature Communications, 14(1), 1-14. https://doi.org/10.1038/s41467-023-40813-w

Monjazeb, Arta M., et al. "Atezolizumab Plus Stereotactic Ablative Radiotherapy for Medically Inoperable Patients with Early-stage Non-small Cell Lung Cancer: A Multi-institutional Phase I Trial." Nature Communications 14, no. 1 (2023): 1-14. https://doi.org/10.1038/s41467-023-40813-w.

Monjazeb, Arta M., et al. "Atezolizumab Plus Stereotactic Ablative Radiotherapy for Medically Inoperable Patients with Early-stage Non-small Cell Lung Cancer: A Multi-institutional Phase I Trial." Nature Communications, vol. 14, no. 1, 2023, pp. 1-14, https://doi.org/10.1038/s41467-023-40813-w.